How Far Into the Future Can a Child with CHD Plan?
What I learned in Denver about the research shaping a brighter future for children with congenital heart disease.
By Candice Schaefer, Chief Development Officer, A Giving Heart Foundation
The Single Ventricle Investigator Meeting in Denver opened with a mom.
Her daughter was born with single ventricle heart disease, one of the most complex forms of congenital heart disease (CHD). She stood in front of a room of scientists, physicians, engineers, and innovators and shared the questions many CHD families may be afraid to ask out loud.
Should we start a college fund? Should we picture kindergarten? Can we plan a family vacation, or do we need to stay close to her cardiology team?
Then she asked the room a question I haven’t stopped thinking about:
“How far into the future can my daughter plan?”
That question stayed with me throughout the three-day meeting, hosted by our partner, Additional Ventures. It gets to the heart of why A Giving Heart Foundation exists: to advance research that opens up more possibilities for children with CHD and the families who love them.
The gap no one talks about
Congenital heart disease is the most common birth defect. Yet pediatric heart research receives only a small share of the funding devoted to other areas of childhood disease research. In Denver, I saw firsthand how researchers are advancing promising ideas despite significant funding challenges.
Developing an advanced heart device for children can take millions and nearly a decade. With a smaller pediatric market, securing the resources needed to bring new technologies from concept to clinical use is a significant challenge.
As a result, physicians and researchers often have to adapt existing technologies to meet children’s unique needs. Devices designed for adults may need to be modified for smaller hearts and growing bodies. Some clinicians and researchers even find ways to adapt stents so they can expand as a child grows.
That ingenuity is remarkable, but children deserve better than workarounds. They deserve research and innovation designed around their unique needs, with the potential to reduce invasive procedures and improve their quality of life.
Where the hope is
For all the challenges, I left Denver more hopeful than I’ve been in a long time. The research underway is helping us imagine new possibilities for children with CHD. Here are a few examples of what researchers are exploring:
- Heart pumps designed for children. Teams are developing heart pumps for patients with Fontan circulation that could one day give children greater freedom to play, learn, and live without being connected to external equipment.
- New answers to why CHD happens. Scientists are investigating how congenital heart disease may involve not only genes but also the way DNA is organized and regulated inside cells. This research could open new avenues for understanding these conditions and developing future treatments.
- Studying heart cells in space. Microgravity can accelerate certain biological aging processes, allowing researchers to study changes in heart cells over shorter periods and investigate questions that could otherwise take much longer to explore.
- Bioprinting living tissue. Researchers are exploring how 3D printing techniques that use living cells and biological materials could one day help repair damaged heart tissue.
These advances are at different stages of research and development, and there is still a long way to go. But seeing the people working to move these ideas forward made the vision of a future with fewer invasive heart surgeries feel more tangible.
There is real progress to build on, and an opportunity to help move it forward.
The research AGHF is funding right now
At A Giving Heart Foundation, we believe every child deserves the opportunity to play, learn, grow, and imagine a future that isn’t defined by congenital heart disease.
Each year, AGHF’s Medical Advisory Board evaluates research opportunities with the potential to improve outcomes and quality of life for children with CHD. Through the generosity of our supporters and strategic research partnerships, we are helping advance promising work today.
Here are three projects making that work tangible.
Preserving living heart valves | Arkansas Children’s Hospital
Dr. Konrad Rajab and his team are developing methods to preserve living heart valves so they can be stored safely and made available when a child needs one.
The long-term potential is significant. Living valves that can grow with a child could help reduce the need for repeat surgeries over a lifetime. This research is one example of how innovation may help us rethink the treatment options available to children with CHD.
The Lumina System | Renata Medical, through Additional Ventures
The Lumina System is a minimally invasive approach being developed for children with single ventricle heart disease. The technology is designed to be delivered by catheter and adjusted as a child grows, with the goal of offering an alternative to additional open-heart procedures for appropriate patients.
Innovations like this reflect an important part of AGHF’s vision: advancing technologies designed around children’s needs and exploring new ways to reduce the burden of invasive procedures throughout childhood.
A fully implantable Fontan pump | Penn State College of Medicine, through Additional Ventures
Dr. William Weiss and his team are developing an implantable pump for children and adults whose Fontan circulation is failing.
I spent time with this team in Denver, and I was struck by their resourcefulness. They build inexpensive prototypes, use sophisticated modeling to manage costs, and find ways to make limited resources go further.
Their work also reinforced something important to me: promising research needs more than a good idea. It needs the resources and flexibility to keep moving forward through the early stages of development.
Flexible early-stage funding can help teams like this continue refining their designs, testing new approaches, and working toward technologies that could make a meaningful difference for people living with complex heart conditions.
Read more about our impact here: What We Do
This is where AGHF and our supporters can play an important role, helping promising ideas progress toward solutions that may change what is possible for children with CHD.
Why our partnership with Additional Ventures matters
No single organization can solve the challenges facing children with single ventricle heart disease alone. Progress depends on researchers, clinicians, institutions, and funders working together toward shared goals.
Additional Ventures brings together a coalition of funders focused on single ventricle heart disease. Through this partnership, AGHF can help support promising research while leveraging additional funding to extend the reach of that investment.
For our supporters, that means their generosity can become part of a broader effort to move important research forward. Strategic partnerships help connect resources, expertise, and innovative ideas, creating more opportunities to advance technologies and treatments for children who need them.
When we work together, we can help promising research go further than any one organization could achieve on its own.
Moving the answer further into the future
I keep coming back to that mom’s question: How far ahead can these families let themselves plan?
We cannot promise exactly what the future will hold. Research takes time, discoveries bring new questions, and not every promising idea becomes a treatment. But we can invest in the people and projects working to make more possible.
Every promising discovery, every new technology, and every step forward brings us closer to a future where children with CHD have more opportunities to play, learn, grow, and imagine what comes next.
Imagine a family feeling more confident about planning for kindergarten. A teenager looking ahead to college. Parents making plans for a family vacation without the same uncertainty about what lies ahead.
These are the possibilities that make this work matter. And they are why continued investment in pediatric heart research is so important.
At A Giving Heart Foundation, we are committed to funding innovative research, supporting meaningful medical advances, and working toward a future where congenital heart disease no longer limits a child’s possibilities.
